105 related articles for article (PubMed ID: 23726027)
21. Preparation and biological evaluation of ⁹⁹mTc-N4IPA for single photon emission computerized tomography imaging of hypoxia in mouse tumor.
Li N; Zhu H; Chu TW; Yang Z
Eur J Med Chem; 2013 Nov; 69():223-31. PubMed ID: 24042045
[TBL] [Abstract][Full Text] [Related]
22. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
24. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.
Chu T; Hu S; Wei B; Wang Y; Liu X; Wang X
Bioorg Med Chem Lett; 2004 Feb; 14(3):747-9. PubMed ID: 14741282
[TBL] [Abstract][Full Text] [Related]
26. Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
Fernández S; Giglio J; Rey AM; Cerecetto H
Bioorg Med Chem; 2012 Jul; 20(13):4040-8. PubMed ID: 22658538
[TBL] [Abstract][Full Text] [Related]
27. The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
Asikoglu M; Durak FG
Appl Radiat Isot; 2009 Sep; 67(9):1616-21. PubMed ID: 19457677
[TBL] [Abstract][Full Text] [Related]
28. Development of superior bone scintigraphic agent from a series of (99m)Tc-labeled zoledronic acid derivatives.
Lin J; Qiu L; Cheng W; Luo S; Xue L; Zhang S
Appl Radiat Isot; 2012 May; 70(5):848-55. PubMed ID: 22381699
[TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of a ⁹⁹mTcN-PNP complex of sanazole analogue for detecting tumor hypoxia.
Mathur A; Mallia MB; Banerjee S; Sarma HD; Pillai MR
Bioorg Med Chem Lett; 2013 Mar; 23(5):1394-7. PubMed ID: 23375795
[TBL] [Abstract][Full Text] [Related]
30. The biological characterization of (99m)Tc-BnAO-NI as a SPECT probe for imaging hypoxia in a sarcoma-bearing mouse model.
Hsia CC; Huang FL; Hung GU; Shen LH; Chen CL; Wang HE
Appl Radiat Isot; 2011 Apr; 69(4):649-55. PubMed ID: 21236690
[TBL] [Abstract][Full Text] [Related]
31. Technetium glucose complexes as potential cancer imaging agents.
Dapueto R; Aguiar RB; Moreno M; Machado CM; Marques FL; Gambini JP; Chammas R; Cabral P; Porcal W
Bioorg Med Chem Lett; 2015 Oct; 25(19):4254-9. PubMed ID: 26318991
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of (99m)Tc-2-[(3-carboxy-1-oxopropyl)amino]-2-deoxy-D-glucose as a potential tumor imaging agent.
Wang Y; Zhu J; Song X; Wang X; Yang J; Zhang J
Bioorg Med Chem Lett; 2014 Aug; 24(16):3882-5. PubMed ID: 25001483
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
34. Preclinical assessment of hypoxic marker specificity and sensitivity.
Iyer RV; Engelhardt EL; Stobbe CC; Schneider RF; Chapman JD
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):741-5. PubMed ID: 9845088
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
[TBL] [Abstract][Full Text] [Related]
36. BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.
Melo T; Duncan J; Ballinger JR; Rauth AM
J Nucl Med; 2000 Jan; 41(1):169-76. PubMed ID: 10647620
[TBL] [Abstract][Full Text] [Related]
37. EGF receptor targeted tumor imaging with biotin-PEG-EGF linked to (99m)Tc-HYNIC labeled avidin and streptavidin.
Jung KH; Park JW; Paik JY; Quach CH; Choe YS; Lee KH
Nucl Med Biol; 2012 Nov; 39(8):1122-7. PubMed ID: 22819251
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole (99m)Tc-complexes as potential agents for targeting hypoxia.
Giglio J; Fernández S; Rey A; Cerecetto H
Bioorg Med Chem Lett; 2011 Jan; 21(1):394-7. PubMed ID: 21087863
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Ballinger JR; Kee JW; Rauth AM
J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of a (99m)Tc-MAMA-propyl-thymidine complex as a potential probe for in vivo visualization of tumor cell proliferation with SPECT.
Celen S; de Groot T; Balzarini J; Vunckx K; Terwinghe C; Vermaelen P; Van Berckelaer L; Vanbilloen H; Nuyts J; Mortelmans L; Verbruggen A; Bormans G
Nucl Med Biol; 2007 Apr; 34(3):283-91. PubMed ID: 17383578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
